4-Thiazolecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-2-[(3,4-dichlorophenyl)methyl]- manufacturers
- BR102910
-
- $78.00
-
2026-07-27
- CAS:2505339-54-6
- Purity: 98.45%
- Supply Ability: 10g
|
| | 4-Thiazolecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-2-[(3,4-dichlorophenyl)methyl]- Basic information |
| Product Name: | 4-Thiazolecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-2-[(3,4-dichlorophenyl)methyl]- | | Synonyms: | 4-Thiazolecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-2-[(3,4-dichlorophenyl)methyl]-;(S)-N-[2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl]-2-(3,4-dichlorobenzyl)thiazole-4-carboxamide;BR102910;FAP Inhibitor,BR102910,POP,inhibit,prolyl oligopeptidase,Inhibitor,BR-102910,BR 102910,Prolyl Endopeptidase (PREP),BR102910;BR102910u00A0;BR102910u00A0, 10 mM in DMSO | | CAS: | 2505339-54-6 | | MF: | C18H14Cl2F2N4O2S | | MW: | 459.3 | | EINECS: | | | Product Categories: | | | Mol File: | 2505339-54-6.mol | ![4-Thiazolecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-2-[(3,4-dichlorophenyl)methyl]- Structure](CAS/20210305/GIF/2505339-54-6.gif) |
| | 4-Thiazolecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-2-[(3,4-dichlorophenyl)methyl]- Chemical Properties |
| Boiling point | 734.5±60.0 °C(Predicted) | | density | 1.55±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | pka | 12.68±0.46(Predicted) | | form | Solid | | color | White to off-white |
| | 4-Thiazolecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-2-[(3,4-dichlorophenyl)methyl]- Usage And Synthesis |
| Uses | BR102910 is a selective fibroblast activation protein (FAP) inhibitor with the IC50 of 2 nM. BR102910 also inhibits prolyl oligopeptidase (PREP) with the IC50 of 49.00 μM. BR102910 can be used for the researchof type 2 | | Biological Activity | BR102910 is a selective fibroblast activation protein (FAP) inhibitor with the IC50 of 2 nM. BR102910 also inhibits prolyl oligopeptidase (PREP) with the IC50 of 49.00 μM. BR102910 can be used for the researchof type 2
BR102910 (C57BL/6J mice, 0-30 mg/kg, Orally, once) shows significant FAP inhibition in a dose dependent manner[1]. | | in vivo | BR102910 (C57BL/6J mice, 0-30 mg/kg, Orally, once) shows significant FAP inhibition in a dose dependent manner[1]. | Animal Model: | C57BL/6J mice (n = 5 per group)[1] | | Dosage: | 0, 10 and 30 mg/kg | | Administration: | Orally, once | | Result: | Showed significant FAP inhibition in a dose dependent manner. |
| | References | [1]. Hui Jin Jung, et al. Identification of BR102910 as a selective fibroblast activation protein (FAP) inhibitor. Bioorg Med Chem Lett. 2021 Apr 1;37:127846. |
| | 4-Thiazolecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-2-[(3,4-dichlorophenyl)methyl]- Preparation Products And Raw materials |
|